|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Crocetti E, Mallone S, Robsahm TE, Gavin
A, Agius D, Ardanaz E, Lopez MC, Innos K, Minicozzi P, Borgognoni
L, et al EUROCARE-5 Working Group, : Survival of patients with skin
melanoma in Europe increases further: Results of the EUROCARE-5
study. Eur J Cancer. 51:2179–2190. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Neagu M, Caruntu C, Constantin C, Boda D,
Zurac S, Spandidos DA and Tsatsakis AM: Chemically induced skin
carcinogenesis: Updates in experimental models (Review). Oncol Rep.
35:2516–2528. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lupu M, Caruntu A, Caruntu C, Papagheorghe
LML, Ilie MA, Voiculescu V, Boda D, Constantin C, Tanase C, Sifaki
M, et al: Neuroendocrine factors: The missing link in non melanoma
skin cancer (Review). Oncol Rep. 38:1327–1340. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Caruntu C, Boda D, Constantin C, Caruntu A
and Neagu M: Catecholamines increase in vitro proliferation of
murine B16F10 melanoma cells. Acta Endocrinol (Copenh). 10:545–558.
2014.
|
|
7
|
Zurac S, Neagu M, Constantin C, Cioplea M,
Nedelcu R, Bastian A, Popp C, Nichita L, Andrei R, Tebeica T, et
al: Variations in the expression of TIMP1, TIMP2 and TIMP3 in
cutaneous melanoma with regression and their possible function as
prognostic predictors. Oncol Lett. 11:3354–3360. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Osborne JE and Hutchinson PE: Vitamin D
and systemic cancer: Is this relevant to malignant melanoma? Br J
Dermatol. 147:197–213. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stumpf WE, Sar M, Reid FA, Tanaka Y and
DeLuca HF: Target cells for 1,25-dihydroxyvitamin D3 in intestinal
tract, stomach, kidney, skin, pituitary, and parathyroid. Science.
206:1188–1190. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Orlow I, Roy P, Reiner AS, Yoo S, Patel H,
Paine S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, et al
GEM Study Group, : Vitamin D receptor polymorphisms in patients
with cutaneous melanoma. Int J Cancer. 130:405–418. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
DeLuca HF: Overview of general physiologic
features and functions of vitamin D. Am J Clin Nutr.
80:1689S–1696S. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bikle DD, Nemanic MK, Gee E and Elias P:
1,25-Dihydroxy-vitamin D3 production by human keratinocytes.
Kinetics and regulation. J Clin Invest. 78:557–566. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Slominski AT, Li W, Kim T-K, Semak I, Wang
J, Zjawiony JK and Tuckey RC: Novel activities of CYP11A1 and their
potential physiological significance. J Steroid Biochem Mol Biol.
151:25–37. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tieu EW, Tang EK and Tuckey RC: Kinetic
analysis of human CYP24A1 metabolism of vitamin D via the
C24-oxidation pathway. FEBS J. 281:3280–3296. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jones G, Strugnell SA and DeLuca HF:
Current understanding of the molecular actions of vitamin D.
Physiol Rev. 78:1193–1231. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Holick MF and Chen TC: Vitamin D
deficiency: A worldwide problem with health consequences. Am J Clin
Nutr. 87:1080S–1086S. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bikle DD: Protective actions of vitamin D
in UVB induced skin cancer. Photochem Photobiol Sci. 11:1808–1816.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schwarz A, Navid F, Sparwasser T, Clausen
BE and Schwarz T: 1,25-dihydroxyvitamin D exerts similar
immunosuppressive effects as UVR but is dispensable for local
UVR-induced immunosuppression. J Invest Dermatol. 132:2762–2769.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Welsh J: Vitamin D metabolism in mammary
gland and breast cancer. Mol Cell Endocrinol. 347:55–60. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miyamoto K, Kesterson RA, Yamamoto H,
Taketani Y, Nishiwaki E, Tatsumi S, Inoue Y, Morita K, Takeda E and
Pike JW: Structural organization of the human vitamin D receptor
chromosomal gene and its promoter. Mol Endocrinol. 11:1165–1179.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Halsall JA, Osborne JE, Potter L, Pringle
JH and Hutchinson PE: A novel polymorphism in the 1A promoter
region of the vitamin D receptor is associated with altered
susceptibilty and prognosis in malignant melanoma. Br J Cancer.
91:765–770. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li C, Liu Z, Zhang Z, Strom SS,
Gershenwald JE, Prieto VG, Lee JE, Ross MI, Mansfield PF, Cormier
JN, et al: Genetic variants of the vitamin D receptor gene alter
risk of cutaneous melanoma. J Invest Dermatol. 127:276–280. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gapska P, Scott RJ, Serrano-Fernandez P,
Mirecka A, Rassoud I, Górski B, Cybulski C, Huzarski T, Byrski T,
Nagay L, et al: Vitamin D receptor variants and the malignant
melanoma risk: A population-based study. Cancer Epidemiol.
33:103–107. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mocellin S and Nitti D: Vitamin D receptor
polymorphisms and the risk of cutaneous melanoma: A systematic
review and meta-analysis. Cancer. 113:2398–2407. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Saijo T, Ito M, Takeda E, Huq AH, Naito E,
Yokota I, Sone T, Pike JW and Kuroda Y: A unique mutation in the
vitamin D receptor gene in three Japanese patients with vitamin
D-dependent rickets type II: Utility of single-strand conformation
polymorphism analysis for heterozygous carrier detection. Am J Hum
Genet. 49:668–673. 1991.PubMed/NCBI
|
|
26
|
Uitterlinden AG, Fang Y, Van Meurs JB,
Pols HA and Van Leeuwen JP: Genetics and biology of vitamin D
receptor polymorphisms. Gene. 338:143–156. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li C, Liu Z, Wang LE, Gershenwald JE, Lee
JE, Prieto VG, Duvic M, Grimm EA and Wei Q: Haplotype and genotypes
of the VDR gene and cutaneous melanoma risk in non-Hispanic whites
in Texas: A case-control study. Int J Cancer. 122:2077–2084. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Randerson-Moor JA, Taylor JC, Elliott F,
Chang YM, Beswick S, Kukalizch K, Affleck P, Leake S, Haynes S,
Karpavicius B, et al: Vitamin D receptor gene polymorphisms, serum
25-hydroxyvitamin D levels, and melanoma: UK case-control
comparisons and a meta-analysis of published VDR data. Eur J
Cancer. 45:3271–3281. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Santonocito C, Capizzi R, Concolino P,
Lavieri MM, Paradisi A, Gentileschi S, Torti E, Rutella S,
Rocchetti S, Di Carlo A, et al: Association between cutaneous
melanoma, Breslow thickness and vitamin D receptor BsmI
polymorphism. Br J Dermatol. 156:277–282. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Barroso E, Fernandez LP, Milne RL, Pita G,
Sendagorta E, Floristan U, Feito M, Aviles JA, Martin-Gonzalez M,
Arias JI, et al: Genetic analysis of the vitamin D receptor gene in
two epithelial cancers: Melanoma and breast cancer case-control
studies. BMC Cancer. 8:3852008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
van Etten E, Verlinden L, Giulietti A,
Ramos-Lopez E, Branisteanu DD, Ferreira GB, Overbergh L, Verstuyf
A, Bouillon R, Roep BO, et al: The vitamin D receptor gene
FokI polymorphism: Functional impact on the immune system.
Eur J Immunol. 37:395–405. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hustmyer FG, DeLuca HF and Peacock M:
ApaI, BsmI, EcoRV and TaqI
polymorphisms at the human vitamin D receptor gene locus in
Caucasians, blacks and Asians. Hum Mol Genet. 2:4871993. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fang Y, van Meurs JB, d'Alesio A, Jhamai
M, Zhao H, Rivadeneira F, Hofman A, van Leeuwen JP, Jehan F, Pols
HA, et al: Promoter and 3′-untranslated-region haplotypes in the
vitamin d receptor gene predispose to osteoporotic fracture: The
Rotterdam study. Am J Hum Genet. 77:807–823. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hutchinson PE, Osborne JE, Lear JT, Smith
AG, Bowers PW, Morris PN, Jones PW, York C, Strange RC and Fryer
AA: Vitamin D receptor polymorphisms are associated with altered
prognosis in patients with malignant melanoma. Clin Cancer Res.
6:498–504. 2000.PubMed/NCBI
|
|
35
|
Han J, Colditz GA and Hunter DJ:
Polymorphisms in the MTHFR and VDR genes and skin cancer risk.
Carcinogenesis. 28:390–397. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mandelcorn-Monson R, Marrett L, Kricker A,
Armstrong BK, Orlow I, Goumas C, Paine S, Rosso S, Thomas N,
Millikan RC, et al: Sun exposure, vitamin D receptor polymorphisms
FokI and BsmI and risk of multiple primary melanoma.
Cancer Epidemiol. 35:e105–e110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hou W, Wan X and Fan J: Variants Fok1 and
Bsm1 on VDR are associated with the melanoma risk: Evidence from
the published epidemiological studies. BMC Genet. 16:142015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zeljic K, Kandolf-Sekulovic L, Supic G,
Pejovic J, Novakovic M, Mijuskovic Z and Magic Z: Melanoma risk is
associated with vitamin D receptor gene polymorphisms. Melanoma
Res. 24:273–279. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Balch CM, Gershenwald JE, Soong SJ,
Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG,
Ding S, et al: Final version of 2009 AJCC melanoma staging and
classification. J Clin Oncol. 27:6199–6206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Letca AF, Ungureanu L, Şenilă SC, Grigore
LE, Pop Ş, Fechete O, Vesa ŞC and Cosgarea R: Regression and
sentinel lymph node status in melanoma progression. Med Sci Monit.
24:1359–1365. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Halsall JA, Osborne JE, Epstein MP,
Pringle JH and Hutchinson PE: The unfavorable effect of the A
allele of the vitamin D receptor promoter polymorphism A-1012G has
different mechanisms related to susceptibility and outcome of
malignant melanoma. Dermatoendocrinol. 1:54–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Schäfer A, Emmert S, Kruppa J, Schubert S,
Tzvetkov M, Mössner R, Reich K, Berking C, Volkenandt M, Pföhler C,
et al: No association of vitamin D metabolism-related polymorphisms
and melanoma risk as well as melanoma prognosis: A case-control
study. Arch Dermatol Res. 304:353–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Orlow I, Reiner AS, Thomas NE, Roy P,
Kanetsky PA, Luo L, Paine S, Armstrong BK, Kricker A, Marrett LD,
et al GEM Study Group, : Vitamin D receptor polymorphisms and
survival in patients with cutaneous melanoma: A population-based
study. Carcinogenesis. 37:30–38. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Orlow I, Shi Y, Kanetsky PA, Thomas NE,
Luo L, Corrales-Guerrero S, Cust AE, Sacchetto L, Zanetti R, Rosso
S, et al GEM Study Group, : The interaction between vitamin D
receptor polymorphisms and sun exposure around time of diagnosis
influences melanoma survival. Pigment Cell Melanoma Res.
31:287–296. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Morgese F, Soldato D, Pagliaretta S,
Giampieri R, Brancorsini D, Torniai M, Rinaldi S, Savini A, Onofri
A, Scarpelli M, et al: Impact of phosphoinositide-3-kinase and
vitamin D3 nuclear receptor single-nucleotide polymorphisms on the
outcome of malignant melanoma patients. Oncotarget. 8:75914–75923.
2017. View Article : Google Scholar : PubMed/NCBI
|
